Reproductive outcome of a patient with congenital adrenal hyperplasia: case report


  • Bhagyashree A. Department of Obstetrics and Gynecology, St. Philomena’s Hospital, Bangalore, Karnataka, India
  • Shylaja A. S. Department of Obstetrics and Gynecology, St. Philomena’s Hospital, Bangalore, Karnataka, India
  • Yashaswini Srikonda Department of Obstetrics and Gynecology, St. Philomena’s Hospital, Bangalore, Karnataka, India



Congenital adrenal hyperplasia, Fertility, Pregnancy


Congenital Adrenal Hyperplasia are a group of inherited autosomal recessive enzymatic defects of adrenal steroid biosynthesis. Low pregnancy rate has been reported in women with CAH. Several factors have been suggested to contribute to this subfertility such as androgen excess, adrenal progesterone hyper secretion, consequences of genital reconstructive surgery, secondary PCOS and psychosexual factors. In contrast to this subfertility, pregnancies are normal and uneventful. During pregnancy, maternal & fetal problems are confined to these deficiencies. Adequate glucocorticoid therapy and improvement of surgical and psychological management could contribute to optimize fertility in CAH. The interposition of the placenta on the HPA axis & other endocrine changes during pregnancy impact considerably on the clinical evaluation of CAH. A 21 years old Primigravida presented to us at 13 weeks of gestation with history of CAH on treatment and vaginoplasty done in the childhood. Endocrinologist opinion was taken, and steroids continued. Advised to meet genetist and follow up for prenatal testing. But patient denied. Antenatal period was uneventful. Patient underwent Emergency LSCS in view of CPD in labour at 36+6 weeks of gestation. Pre-op stress dose of steroid given. A girl baby of birth weight 2.13 kg was born with good Apgar scores. Perioperative period uneventful. Preconception health, including hormonal, psychosexual and anatomical barriers to fertility should be addressed early in women with CAH. This review provides fertility outcome and pregnancy issues of a woman with CAH.


Al-Agha, A., A. Ocheltree, and M. Al-Tamimi, Association between genotype, clinical presentation,and severity of congenital adrenal hyperplasia: a review. Turkish J Pediat, 2012.54(4):323-32.

Lin-Su K, Nimkarn S, New MI. Congenital adrenal hyperplasia in adolescents: diagnosis and management. Ann N Y Acad Sci 2008;1135(1):95-8.

Belinda G, Vinay D, Moolechery J, Mathew V, Anantharaman R, Ayyar V, et al Congenital adrenal hyperplasia -experience from a tertiary centre in South India. IndianJournal of Endocrinology and Metabol. 2012;16(2):S385-6.

Mahdi Kamoun, M.M.F., Mohamed Habib Sfar, and Mohamed Abid, Congenital adrenal hyperplasia: Treatment and outcomes. Indian J Endocrinol Metabol. 2013.17(1):p.S14-17.

Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.N Engl J Med 1987;316:178-82.

Gonzalez, R. and B. Ludwikowski, Should the genitoplasty of girls with CAH be done in one or two stages? Frontiers in Pediatrics, 2014.1(54):1-2.

Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency-management in adults. Endokrynol Pol. 2010;61(1):142-55.

Witchel SF. Management of CAH during pregnancy: Optimizing outcomes. Curr Opin Endocrinol Diabetes Obes. 2012;19(6):489-96.






Case Reports